Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 03 apr 2012 - 07:08
Statutaire naam Esperite N.V.
Titel Cryo-Save Group N.V.: Grant of share options
Bericht Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage brand and the largest family stem cell bank in Europe, announces that the Group granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2009 Share Option Scheme on 2 April 2012. The Group granted 20,000 options to Arnoud van Tulder, Chief Executive Officer, and 44,000 options to certain other employees of the Group all at an exercise price of €3.93 per share, being the price equal to the arithmetic average of the closing mid-market price over the five dealing days prior to the date of the grant. All of these options are exercisable at any time from 3 April 2015 until 3 April 2022.